Literature DB >> 30643571

The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer.

Paraskevi Boura1,1, Dimitra Grapsa1,1, Stylianos Loukides1,1, Maria Angelidou2,2, Konstantina Tsakanika3,3, Nikolaos Syrigos1,1, Ioannis Gkiozos1,1.   

Abstract

AIM: We aimed to explore the prognostic implications of adiponectin (APN) levels in the serum and bronchoalveolar lavage (BAL) of patients with advanced NSCLC. MATERIALS &
METHODS: 29 newly diagnosed patients with stage IV NSCLC were prospectively enrolled. Baseline serum and BAL levels of APN were assayed by ELISA and correlated with various clinicopathological parameters, including overall survival.
RESULTS: No statistically significant correlations were observed between the serum or BAL levels of APN and the clinicopathological parameters evaluated. The only prognostic factor identified, both by univariate and multivariate survival analyses, was performance status.
CONCLUSION: The results of our cohort failed to reveal any prognostic significance of serum and BAL levels of APN in stage IV NSCLC.

Entities:  

Keywords:  NSCLC; adiponectin; bronchoalveolar lavage; serum

Year:  2017        PMID: 30643571      PMCID: PMC6310335          DOI: 10.2217/lmt-2016-0018

Source DB:  PubMed          Journal:  Lung Cancer Manag        ISSN: 1758-1966


  51 in total

1.  Association between adiponectin, insulin resistance, and endometrial cancer.

Authors:  Pamela T Soliman; Diana Wu; Guillermo Tortolero-Luna; Kathleen M Schmeler; Brian M Slomovitz; Molly S Bray; David M Gershenson; Karen H Lu
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

2.  Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases.

Authors:  Ferit Avcu; A Ugur Ural; M Ilker Yilmaz; Necati Bingol; Oral Nevruz; Kayser Caglar
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

3.  Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.

Authors:  Ido Wolf; Seigal Sadetzki; Hannah Kanety; Yulia Kundel; Clara Pariente; Nava Epstein; Bernice Oberman; Raphael Catane; Bella Kaufman; Ilan Shimon
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

4.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.

Authors:  Eleni Petridou; Christos Mantzoros; Nick Dessypris; Panagiotis Koukoulomatis; Carol Addy; Zannis Voulgaris; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

5.  Prostate cancer and adiponectin.

Authors:  Serdar Goktas; Mahmut Ilker Yilmaz; Kayser Caglar; Alper Sonmez; Selim Kilic; Selahattin Bedir
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

6.  Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.

Authors:  Esther K Wei; Edward Giovannucci; Charles S Fuchs; Walter C Willett; Christos S Mantzoros
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

7.  Plasma adiponectin and gastric cancer.

Authors:  Makoto Ishikawa; Joji Kitayama; Shinsuke Kazama; Takeyuki Hiramatsu; Kenji Hatano; Hirokazu Nagawa
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

8.  Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.

Authors:  Nigel B Jamieson; Duncan J F Brown; A Michael Wallace; Donald C McMillan
Journal:  Cytokine       Date:  2004 Jul 21-Aug 7       Impact factor: 3.861

9.  Association of serum adiponectin levels with breast cancer risk.

Authors:  Yasuo Miyoshi; Tohru Funahashi; Shinji Kihara; Tetsuya Taguchi; Yasuhiro Tamaki; Yuji Matsuzawa; Shinzaburo Noguchi
Journal:  Clin Cancer Res       Date:  2003-11-15       Impact factor: 12.531

10.  Adiponectin and breast cancer risk.

Authors:  Christos Mantzoros; Eleni Petridou; Nick Dessypris; Charilaos Chavelas; Maria Dalamaga; Delia Marina Alexe; Yannis Papadiamantis; Christos Markopoulos; Evangelos Spanos; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

View more
  1 in total

1.  Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: A Case-Control Study.

Authors:  Ersilia Nigro; Fabio Perrotta; Maria Ludovica Monaco; Rita Polito; Pia Clara Pafundi; Maria Gabriella Matera; Aurora Daniele; Andrea Bianco
Journal:  Biomolecules       Date:  2020-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.